Nurix Therapeutics Announces Regulatory Clearance to
U.K. regulatory authorities grant Clinical Trial Authorization with dosing of first patient anticipated in the first half of 2022 NX‑5948 crosses the...
Source: globenewswire.com
Stay updated with breaking news from Selective Degrader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.K. regulatory authorities grant Clinical Trial Authorization with dosing of first patient anticipated in the first half of 2022 NX‑5948 crosses the...